Cai, Qingxian

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. [electronic resource] - Engineering (Beijing, China) Oct 2020 - 1192-1198 p. digital

Publication Type: Journal Article

2095-8099

10.1016/j.eng.2020.03.007 doi